ANTHONY JOHNSON: Open Payments
NPI 1396230116 · BOUNTIFUL, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 17 payments from 9 companies in 2025. Trend: 2023 $141 · 2024 $256 · 2025 $409
Food & beverage: $310Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $116 |
| Janssen Biotech, Inc. | 1 | $99 |
| ABBVIE INC. | 5 | $91 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| LEO Pharma Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| Botanix SB Inc | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Organon LLC | 1 | $2 |
Products named: TREMFYA, COSENTYX, SKYRIZI, LIBTAYO, ADBRY, EBGLYSS, SOFDRA, Sotyktu.
Industry payments across UT — which companies pay providers there.
